The ConnectedCancerCare Pilot Study (CCC)
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Breast Cancer, Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - 84 |
| Updated: | 8/17/2018 |
| Start Date: | August 1, 2018 |
| End Date: | November 30, 2019 |
Patient-Centered, Team-Based Continuing Care After Breast Cancer Treatment: The ConnectedCancerCare Pilot Study
This study is an NCI-funded, randomized control pilot trial to evaluate: (1) the feasibility
and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2)
explore whether the tool improves delivery of team-based survivorship care for women who have
recently finished primary breast cancer treatment.
and acceptability of a web-based, personalized navigation tool (ConnectedCancerCare) and (2)
explore whether the tool improves delivery of team-based survivorship care for women who have
recently finished primary breast cancer treatment.
This study is a randomized control pilot trial involving 60 women newly diagnosed with
early-stage breast cancer who are finishing primary treatment. Participants will be
randomized either to the intervention arm (CCC website that provides information on
team-based follow-up care for both cancer surveillance and preventive care) or the control
arm (static online survivorship care plan template, adapted from the ASCO breast cancer
survivorship template). The feasibility and acceptability of the tool and correlations with
patient-reported outcomes will be assessed 3 months following the completion of a baseline
survey via an online follow-up survey.
early-stage breast cancer who are finishing primary treatment. Participants will be
randomized either to the intervention arm (CCC website that provides information on
team-based follow-up care for both cancer surveillance and preventive care) or the control
arm (static online survivorship care plan template, adapted from the ASCO breast cancer
survivorship template). The feasibility and acceptability of the tool and correlations with
patient-reported outcomes will be assessed 3 months following the completion of a baseline
survey via an online follow-up survey.
Inclusion Criteria:
- Diagnosed with early Stage (0-IIB) breast cancer
- Must be a patient of a University of Michigan Breast Cancer Oncologist
- Must be completing primary cancer treatment and transitioning into survivorship
- Must be able to speak, read and write in English
- Must have access and the ability to use the internet
Exclusion Criteria:
- Diagnosed with stage III or IV breast cancer
- Unable to speak, read, and write in English
We found this trial at
1
site
1500 East Medical Center Drive
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
Click here to add this to my saved trials
